Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Statistics

Total Valuation

QNRX has a market cap or net worth of $10.44 million. The enterprise value is -$1.43 million.

Market Cap	10.44M
Enterprise Value	-1.43M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

QNRX has 1.80 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.80M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	3.17%
Owned by Institutions (%)	50.77%
Float	1.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.19
P/TBV Ratio	1.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.25.

Current Ratio	2.87
Quick Ratio	2.63
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -231.18% and return on invested capital (ROIC) is -111.12%.

Return on Equity (ROE)	-231.18%
Return on Assets (ROA)	-76.20%
Return on Invested Capital (ROIC)	-111.12%
Return on Capital Employed (ROCE)	-168.79%
Weighted Average Cost of Capital (WACC)	11.47%
Revenue Per Employee	n/a
Profits Per Employee	-$2.83M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.31% in the last 52 weeks. The beta is 1.75, so QNRX's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-24.31%
50-Day Moving Average	6.77
200-Day Moving Average	9.68
Relative Strength Index (RSI)	42.15
Average Volume (20 Days)	22,784

Short Selling Information

The latest short interest is 85,556, so 4.74% of the outstanding shares have been sold short.

Short Interest	85,556
Short Previous Month	80,474
Short % of Shares Out	4.74%
Short % of Float	5.57%
Short Ratio (days to cover)	2.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.46M
Pretax Income	-16.99M
Net Income	-16.99M
EBITDA	-17.36M
EBIT	-17.46M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $14.04 million in cash and $2.17 million in debt, with a net cash position of $11.87 million or $6.58 per share.

Cash & Cash Equivalents	14.04M
Total Debt	2.17M
Net Cash	11.87M
Net Cash Per Share	$6.58
Equity (Book Value)	8.77M
Book Value Per Share	n/a
Working Capital	9.99M

Cash Flow

Operating Cash Flow	-15.82M
Capital Expenditures	n/a
Depreciation & Amortization	100,000
Net Borrowing	-600,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-162.69%
FCF Yield	n/a

Analyst Forecast

The average price target for QNRX is $30.00, which is 418.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	418.14%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 1:35.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	1:35

Scores

Altman Z-Score	n/a
Piotroski F-Score	3